Sotevtamab, a novel dual-action agent, is sparking considerable excitement within the cancer community, particularly regarding the potential for managing blood malignancies . The therapy functions by https://keziajnkg544767.blogdigy.com/sotevtamab-a-new-treatment-in-blood-malignancies-66445572